In contrast, type II RCM, characterized by the complete or almost complete loss of activity of the CYB5R3 enzymes leads to devastating developmental and neurological disease in humans, likely due to fatty acid disturbances besides methemoglobinemia [10,11]. Here, CYB5R3 is linked to nervous system disorder.